Aviv Regev
Bioinformatician
From Wikipedia, the free encyclopedia
Aviv Regev (Hebrew: אביב רגב; born 11 July 1971)[1] is an Israeli-American computational and systems biologist serving as Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche.[2] Previously, she was a core member and professor at the Broad Institute of MIT and Harvard and at the Department of Biology of the Massachusetts Institute of Technology.[3] Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She co-founded the Human Cell Atlas project,[4] together with Sarah Teichmann. Since 2024, she has served as a scientific advisory board member of Arc Institute.[5]
.jpg)
Aviv Regev | |
|---|---|
אביב רגב | |
Regev at the Intelligent Systems for Molecular Biology conference in 2017 | |
| Born | July 11, 1971[1] |
| Alma mater | Tel Aviv University (M.Sc., Ph.D.) |
| Scientific career | |
| Fields | Bioinformatics Computational Biology |
| Workplaces | |
| Eva Jablonka Ehud Shapiro | |
| Website | www |
Education
Regev studied at the Adi Lautman Interdisciplinary Program for Outstanding Students of Tel Aviv University, where she completed her PhD under the supervision of Eva Jablonka,[6] and Ehud Shapiro.[7]
Career and research
In 2020, Regev became the head and executive vice president of Genentech Research and Early Development, based in South San Francisco, and a member of the extended corporate executive committee of Roche.[8][9] Previously, she was a Core Institute Member, chair of the Faculty, founding director of the Klarman Cell Observatory and co-director Cell Circuits Program at the Broad Institute of MIT and Harvard. She was also a professor in the Department of Biology at the Massachusetts Institute of Technology, as well as an investigator at the Howard Hughes Medical Institute. Regev's research[10] includes work on gene expression[11][12] (with Eran Segal and David Botstein), and the use of π-calculus to represent biochemical processes.[13][14][15] Regev's team has been a leading pioneer of single-cell genomics experimental and computational methods.[16] In 2014, she pitched the idea of the creation of Human Cell Atlas,[17] a project to describe all cell types in the human body. Regev founded the Human Cell Atlas together with Sarah Teichmann along with collaborators all over the world.[18]
Single Cell Genomics
Regev's lab pioneered the development and application of many of the key experimental and computational advances for single cell and spatial genomics, especially single cell RNA-Seq (scRNA-seq).
Fellowships and memberships
- Associate member of the European Molecular Biology Organization in 2024[19]
- Foreign member of the Royal Society [20]
- Elected to the American Academy of Arts and Sciences, 2022[21]
- Fellow of the American Association for Cancer Research (AACR) (2021)[22]
- Helmholtz Fellow (2020),[23]
- Member of the US National Academy of Medicine (NAM, elected 2020)[24]
- Member of the US National Academy of Sciences (NAS, elected 2019)[25]
- Fellow of the International Society of Computational Biology (ISCB) (2017) [26]
Awards and honors
- Meyenburg Prize for her outstanding achievements in cancer research (2026) [27]
- Dickson Prize in Science, 2025[28]
- William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, 2025[29]
- Sune Bergström Award, 2025 [30]
- Shai Shacknai Memorial Prize and Lectureship in Immunology and Cancer Research, 2024 [31]
- 25th L'Oréal-UNESCO For Women in Science Awards (Laureate for North America), 2023[32]
- Nakasone Award from the Human Frontiers Science Program (2022)[33]
- Honorary doctorate, ETH Zurich (2021)[34]
- Ernst Schering Prize (2021)[35]
- James Prize in Science and Technology Integration, National Academy of Sciences (2021)[36]
- Vanderbilt Prize (2021)[37]
- 25th Keio Medical Science Prize in 2020[38][39]
- Lurie Prize from the Foundation for the NIH (FNIH) (2020)[40]
- Jonathan Kraft Prize from Massachusetts General Hospital (2020)[41]
- FASEB Excellence in Science Mid-Career Investigator Award (2019)[42]
- Served on the Life Sciences jury for the Infosys Prize in 2018.
- ISCB Innovator Award in 2017[44][45]
- Earl and Thressa Stadtman Scholar Award from the American Society of Biochemistry and Molecular Biology (ASBMB) (2014)[46]
- Burroughs Wellcome Fund Career Award [47]
- Overton Prize in 2008 for "outstanding accomplishment to a scientist in the early to mid stage of his or her career".[50]
Named lectures and Keynote addresses
- Omenn Lecture, University of Michigan Medical School, 2026[51]
- Keynote address at ISSCR 2026 Annual Meeting in Montréal, 2026[52]
- National Academy of Medicine Annual Meeting Keynote, 2025[53]
- Streisinger Memorial Lecture, 2025[54]
- Anderson Lecture, University of Virginia, 2022[57]
- AACR-Irving Weinstein Foundation Distinguished Lecture (2021)[58]
- Mendel Lecture, European Society of Human Genetics (2020)[59]
- Weatherall Lecture, University Oxford, UK (2018)[60]
- Harvey Lecture, Harvey Society, New York (2018)[61]
- McCormick Lecture, Stanford University (2018)[62]
